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Seborrheic pemphigoid (SP), first described in 1969 by Schnyder, is a peculiar variant of BP which clinically resembles pemphigus
erythematosus, since it is characterized by ruptured bullae and erosions covered with crusts involving the seborrheic areas. To the
best of our knowledge, from the first description only four other cases of SP have been reported, of which two are in the English
literature. We report an additional case of SP in a 56-year-old man with cervical spondylogenic myelopathy with very impaired
mobility.
1. Introduction
Bullous pemphigoid (BP) is a chronic, autoimmune, often
pruritic, subepidermal, blistering dermatosis occurring
mainly in elderly individuals aged 70 years and older. Classi-
cally, patients present with large tense bullae on apparently
normal or erythematous skin, located at the sides of the neck,
axillae, groins, upper inner aspects of the thighs, and abdo-
men.Not rarely, excoriated, eczematous, papular, or urticarial
lesions may precede the onset of the blisters [1, 2]. In addition
to the more classic findings, several atypical presentations
of BP have been described, including forms confined to a
particular cutaneous district (paralyzed extremity, pretibial
area, umbilicus, vulva, and irradiated or peristomal sites) and
variants presenting with vesicular, erythroderma, vegetating,
dyshidrotic dermatitis-like, prurigo nodularis-like, toxic
epidermal necrolysis-like, ecthyma-like, or pemphigus ery-
thematosus-like lesions [2, 3].
The latter variant is known as “seborrheic pemphigoid”
and is a very rare form of BP, since there are only a few
cases reported in the literature. We report an additional case
of seborrheic pemphigoid in a patient with cervical spon-
dylogenic myelopathy with very impaired mobility.
2. Case Report
A 56-year-old man presented to our clinic with a three-
month history of recurrent and mild itchy bullae quickly
evolving in erosive lesions covered by crusts located on
his scalp, forehead, auricular and periauricular regions, and
interscapular area (seborrheic sites). The patient had been
previously diagnosed as having impetigo and seborrheic
dermatitis; however, specific therapies for these disorders
were found to be completely ineffective. His medical history
included an untreated progressive (during previous 4 years)
slight bilateral age-related sensorineural hearing loss (pres-
bycusis); bipolar disorder (since he was 35 years old) con-
trolled from about 5 years with quetiapine, duloxetine, and
lorazepam; and cervical spondylogenicmyelopathy with very
limited mobility (from about 2 years) which had worsened
considerably in the last six months. The cervical problem has
been treated only with physical therapies (but the patient is
currently waiting for a surgical treatment). The man denied
other drugs intake and health issues. Physical examination
revealed very few flaccid blisters, several erosions (some of
which with a peripheral epithelial collarette), and hematic
and serous crusts on a slightly erythematous background
Hindawi Publishing Corporation
Case Reports in Dermatological Medicine
Volume 2014, Article ID 768217, 4 pages
http://dx.doi.org/10.1155/2014/768217
2 Case Reports in Dermatological Medicine
(a) (b) (c)
Figure 1: Several erosions (some of which with a peripheral epithelial collarette) and hematic and serous crusts on a slightly erythematous
background on forehead (a), right periauricular region (b), and interscapular area (c); a flaccid blister (arrow) is visible under the right ear
lobe (b).
(a) (b)
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Figure 2: Subepidermal bulla containing eosinophils with an eosinophilic inflammatory cell infiltrate in the superficial dermis (H and
E staining, magnification ×100) (a); detail of eosinophils in the subepidermal blister (H and E staining, magnification ×400) (b). Direct
immunofluorescence tests show deposition of IgG (c) and C3 (d) at the basement membrane zone (200x).
(Figures 1(a), 1(b), and 1(c)); Nikolsky’s sign was absent.
No other significant skin or mucosal lesions were seen. A
6mm punch biopsy specimen was taken from the edge of
a blister of right periauricular region and submitted for
histological examination, which showed subepidermal bulla
containing eosinophils with an eosinophilic inflammatory
cell infiltrate in the superficial dermis (Figures 2(a) and
2(b)). Direct immunofluorescence (IF) of perilesional skin
detected IgG and C3 deposition at the basement membrane
zone (Figures 2(c) and 2(d)). The result of immunoblotting
showed IgG autoantibodies which reacted against BP230
in epidermal extracts; furthermore, the BP180 antibodies
were also detected (value of 31.7U/mL; cutoff value for
positivity: 15.0U/mL) by an enzyme-linked immunosorbent
assay (ELISA) BP180-NC16a diagnosis kit. The detection of
antinuclear and antiextractable nuclear antigens antibodies
was negative. On the basis of clinical, histological, and
laboratory findings, a diagnosis of seborrheic pemphigoid
was made. Treatment with oral methylprednisolone at the
dosage of 0.5mg/kg/die mg produced a rapid improvement.
After 5 weeks the patient achieved a complete remission and
the steroid was gradually tapered during the subsequent 6
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months up to dose of 0.1mg/kg/die. The value of circulating
anti-BP180-NC16a antibodies (ELISA test) was also progres-
sively decreased (26.4U/mL after 5 weeks, 21.6U/mL after
3 months, and 18.1 U/mL after 6 months). Currently, after 9
months from the start of steroid therapy, the patient is free of
disease and presents a value of circulating anti-BP180-NC16a
antibodies under the cutoff value for positivity (13.2U/mL)
with a dose of methylprednisolone of 0.1mg/kg/die.
3. Discussion
Seborrheic pemphigoid (SP) is a peculiar variant of BP which
clinically resembles pemphigus erythematosus (known also
as seborrheic pemphigus), since it is characterized by rup-
tured bullae and erosions covered with crusts involving the
seborrheic areas [4]. The first instance of SP reported in the
literature dates back to 1969, when Schnyder described a case
in an elderly female [5]. It is important to underline that all
cases [6–16] described as “SP” before Schnyder’s report were
actually instances of pemphigus erythematosus [5]. Such
confusion was probably caused by the lack of availability
of reliable serological tests and direct IF test of perilesional
skin, which are very helpful particularly in the cases without
detectable bullae [1, 17, 18]. To the best of our knowledge,
since the first description four other instances of SP, similar to
our case and original report of Schnyder, have been reported
[1, 4, 17, 18], of which two are in English language in 1991
[18] and 2002 [1], respectively. Regarding the latter report, the
authors emphasized a possible association between losartan
intake and unleashing of the lesions in their patient [1].
When a blister is available, its histological examination
shows a picture comparable to the classic form of BP, with a
subepidermal cleavage [1]. Direct IF test of perilesional skin,
which generally reveals linear deposition of IgG and C3 at
the dermoepidermal junction [1], and detection of circulating
IgG antibodies against basement membrane zone (indirect
IF), BP230, and/or BP180may be of aid in the diagnosis [1, 18].
The reasons underlying the peculiar location of the
lesions in seborrheic areas in SP are not clear. It is well-known
that the regional variability in the BP antigens skin expression
may play a role in the distribution of the lesions of BP, given
that the greatest concentration of BP antigens is in the skin of
flexor surfaces of the arm, leg, and thigh, the most common
sites involved in BP [19]. On the basis of this finding, it is
possible to speculate that subjects with SP could present a
higher expression of BP antigens in the seborrheic areas than
the rest of the skin surface. Unfortunately, our patient denied
further skin biopsies and therefore we have not been able
to assess this hypothesis. We hope that future studies may
evaluate this assumption. Another possible explanation for
the peculiar localization of the lesion in SP could be that
unknown factors typical of seborrheic areas may trigger or
aggravate the disease in susceptible individuals. In this view,
it is important to underline the ability of Malassezia yeast,
which is notoriously localized to seborrheic sites, to activate
the complement system, via either the alternative pathway
or the classical pathway, with the possibility to amplify the
complement-mediated inflammation which is characteristic
of BP [20]. Considering that an increase of the static pool
of already secreted sebum due to immobility and muscular
paralysis plays a permissive role for growth of Malassezia
yeast [21], the possible involvement of this microorganism
could also explain a possible correlation between SP and cer-
vical spondylogenic myelopathy with very limited mobility
in our patients. In fact, albeit we can not exclude a coin-
cidental association, there are three points that support a
such link: the development of the disease after a relatively
brief period from the significant worsening of the motor
abilities, the age of onset lower than the average [3], and the
well-known correlation between classical pemphigoid and
neurodegenerative processes [22, 23].
Although SPmay sometimes be confusedwith seborrheic
dermatitis or impetigo, the main differential diagnosis is
pemphigus erythematosus. In our opinion, the negativity of
Nikolsky’s sign, as described in the present case, may help to
suspect a SP rather than pemphigus erythematosus, since in
the latter it is almost always present [24]. Anyhow, only the
histology, direct immunofluorescence examination, and sero-
logical studies allow us to definitely distinguish SP frompem-
phigus erythematosus and the other conditions mentioned
above.
With regard to the therapy, according to other authors
[3], our case confirms that relatively low dosages of systemic
corticosteroids are effective in SP.
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